QA: Avadel Pharmaceuticals PLC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001012477_2021_Avadel_Pharmaceuticals_PLC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001012477, Avadel Pharmaceuticals PLC

  xvar xval
0 AssetsCurrent 263,454,000
1 IntangibleAssetsNetIncludingGoodwill 16,836,000
2 PropertyPlantAndEquipmentNet 359,000
3 remainder_Assets 30,988,000
4 LiabilitiesCurrent 15,109,000
5 LiabilitiesNoncurrent 134,262,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,685,786
8 SellingGeneralAndAdministrativeExpense 33,724,651
9 ResearchAndDevelopmentExpense 14,953,439
10 remainder_Expenses -38,193,948
11 remainder_Revenues 22,583,222
12 remainder_NetIncome 573,682
13 remainder_ComprehensiveNetIncome 1,388,654
  yvar yval
0 Assets 311,637,000
1 Liabilities 149,371,000
2 Expenses 12,169,928
3 Revenues 22,583,222
4 StockholdersEquity 162,266,000
5 NetIncome 10,986,976
6 ComprehensiveNetIncome 11,681,303
7 BaseVar 248,861,743
8 EconomicCapitalRatiobeforeLimitedLiability 1.59
9 EconomicCapitalRatio 2.74

Edgar->Model Mapping

Feature Distribution

Change over Time